Objectively speaking, it would hard to believe a seasoned analyst with expertise in the tobacco industry would rate higher than 'neutral'. If she does cover it she would of course reference the highlights such as patents, imminent product launch, and marihuana, but balance it with high short interest, volatile stock price fluctuation, and no meaningful earnings. As one of the largest private shareholders, I certainly would be excited with any rating above neutral but it's just that I don't expect it at this time. This is a long term investment as you know so I'm just patiently waiting for earning growth which I expect over the next 12 months.
Market Data 
Markets 
AI
